Pfizer

A fourth shot will be needed as the power of the booster wanes, Moderna CEO Stephane Bancel stated on Thursday while addressing a Goldman Sachs healthcare conference. His comments were the first such definitive statement by Moderna regarding the need...

Pfizer and BioNTech announced on Wednesday that they will work together to develop an MRNA vaccine for the viral infection called shingles. The pharmaceutical companies worked together to create the world's first fully-approved MRNA vaccine for the coronavirus in 2020. They...

CNN Business has named Pfizer CEO Albert Bourla, a Thessaloniki native who left Greece at the age of 34 to pursue a career in the pharmaceuticals industry, as the CEO of the year. CNN says that Bourla was their choice...

The US Food and Drug Administration approved Pfizer's Covid-19 pill for use on Wednesday. Pfizer filed for U.S. authorization of the the antiviral Covid-19 pill in late November. The pill, called Paxlovid, can now be prescribed by doctors for high-risk...

The Centers for Disease Control and Prevention on Thursday recommended the Pfizer and Moderna Covid vaccines over Johnson & Johnson's vaccine. The CDC's advisers pointed to the mounting evidence that the company's vaccine has the potential to set off a...

After exactly one year after Americans began receiving vaccines against the coronavirus, it is time to take stock and look at some sobering numbers as the death toll in the country tops 800,000. Just one year ago, on December 14,...

Pfizer CEO Albert Bourla told CNBC on Thursday that we may need a fourth vaccine dose "faster" in order to combat the omicron variant of Covid-19. Bourla had previously said that he anticipated the fourth shot to only be necessary...

Officials from Pfizer and BioNTech, the firms that produced the very first coronavirus vaccine, said that three inoculations of their product "neutralized" the omicron variant in new laboratory tests. They then announced that they could deliver a reformulated vaccine in...

German pharmaceutical company Merck said on Friday that its anti-Covid pill was found to be 20% less effective in a final analysis of a clinical trial. The drug, called molnupiravir, was initially estimated to cut the risk of hospitalization and...

The first long-term study of Pfizer’s Covid-19 vaccine is out -- and the results show that the shot is 100% effective against the coronavirus in those 12 to 15 years of age, it was announced on Monday. Officials from Pfizer...